BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 32910747)

  • 1. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
    Ma X; Ren H; Zhang Y; Wang B; Ma H
    Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA RHPN1-AS1 accelerates proliferation, migration, and invasion via regulating miR-485-5p/BSG axis in hepatocellular carcinoma.
    Zhang W; Han L; Xing P; Liu B; Sun Z; Zhou W; Dong J
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2543-2551. PubMed ID: 32435875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
    Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
    Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
    Dong H; Jian P; Yu M; Wang L
    J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X; Wang Y
    Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 12. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
    Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
    Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
    Huang C; Li K; Huang R; Zhu J; Yang J
    Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis.
    Huang Y; Xiang B; Liu Y; Wang Y; Kan H
    Cancer Lett; 2018 Nov; 437():56-66. PubMed ID: 30165194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway.
    Liu J; Liu R; Liu Y; Li L; Cao H; Liu J; Cao G
    Cell Cycle; 2021 Jun; 20(12):1134-1146. PubMed ID: 34097562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
    Li J; Zhai DS; Huang Q; Chen HL; Zhang Z; Tan QF
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6091-6104. PubMed ID: 31364110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
    Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
    Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.